Molecular mechanisms involved in doxorubicin-induced cardiotoxicity: A bibliometrics analysis by VOSviewer
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-04 · 397 (4) · 1971-1984
DOI: 10.1007/s00210-023-02773-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 09.10.2023. Verfasst von Fatemeh Yarmohammadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Cardiotoxicity, Apoptosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Doxorubicin is a potent chemotherapeutic agent that can cause cardiotoxicity. Many documents (more than 14,000) have been published in the area of doxorubicin-induced cardiotoxicity (DIC) since 1970. A comprehensive bibliographic analysis of author keywords was used to describe better and understand the molecular mechanisms involved in DIC. The objective was to consider the state of the author keywords of research on the molecular mechanisms involved in DIC based on a bibliometrics study of articles published over the past fifty years. A bibliometrics analysis was conducted using VOSviewer with data collected from the Web of Science Core Collection database of over 14,000 documents (from 1970 to July 19, 2023). Using scientific publications retrieved about DIC, author keywords were assessed at the scientific field level. The current study showed that the annual number of DIC-related publications has increased over the past 50 years. The Journal of Clinical Oncology is the leading journal in this field. The top cited DIC document was published in 2004. The top keywords with high frequency were "doxorubicin," "cardiotoxicity," and "adriamycin." According to the results of this study, the most common mechanisms involved in DIC were as follows oxidative stress, apoptosis, inflammation, autophagy, mitophagy, endoplasmic reticulum stress, pyroptosis, and ferroptosis. The highest occurrences of regulators-related author keywords were "AKT," "Sirt1," and "AMPK." Based on the findings, oxidative stress, apoptosis, inflammation, autophagy, mitophagy, endoplasmic reticulum stress, pyroptosis, and ferroptosis were hot research mechanisms of DIC from 1970 to July 19, 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- University of South Florida College of Public Health, Tampa, FL, USA.
- Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. karimig@mums.ac.ir.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. karimig@mums.ac.ir.
ORCID-Profile: Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi
Zitieren
APA
Yarmohammadi, F., Wallace Hayes, A., & Karimi, G. (2024). Molecular mechanisms involved in doxorubicin-induced cardiotoxicity: A bibliometrics analysis by VOSviewer. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(4), 1971-1984. https://doi.org/10.1007/s00210-023-02773-2
Vancouver
Yarmohammadi F, Wallace Hayes A, Karimi G. Molecular mechanisms involved in doxorubicin-induced cardiotoxicity: A bibliometrics analysis by VOSviewer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(4):1971-1984. doi:10.1007/s00210-023-02773-2
BibTeX
@article{Yarmohammadi2024,
author = {Yarmohammadi, Fatemeh and Wallace Hayes, A and Karimi, Gholamreza},
title = {Molecular mechanisms involved in doxorubicin-induced cardiotoxicity: A bibliometrics analysis by VOSviewer},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
volume = {397},
number = {4},
pages = {1971--1984},
doi = {10.1007/s00210-023-02773-2}
}
EUVIMED